International network and affiliated investigators
In CCBIO, we have extensive and increasing external collaboration. Activities such as international contacts and projects have been well established by all PIs.
International affiliated researchers
The CCBIO International Faculty consists of internationally high-ranking scientists within relevant fields of cancer research. They mostly have 10% adjunct professor or researcher positions at CCBIO. The early establishment of such firm collaborative ties has increased CCBIO’s ability to perform cutting-edge research by conducting joint projects, facilitating the transfer of knowledge, and by receiving high-level strategic advice and support. This has successfully strengthened CCBIO’s collaborative networks as well as its research. Another important aim has been to enable CCBIO’s Research School to organize research-based courses at the highest level and to enable co-supervision and exchange of PhD candidates and postdoctoral fellows.
In 2022, CCBIO’s International Faculty numbered 14 affiliated investigators, and CCBIO clearly feels that this unique group has strongly supported the center’s many activities and efforts.
Please find below short bios about all our affiliated investigators.
Professor Frédéric Amant, PhD and MD, received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998, and his subspecialty training in gynecologic oncology in 2000.
Rameen Beroukhim got his PhD at the University of Cambridge in 1996 and his MD at the University of California in 2000. He is currently a physician in the Department of Medical Oncology at the Dana-Farber Cancer Institute, an associate physician in medical oncology at Brigham and Women’s Hospital...
Dr. Jean-Christophe Bourdon earned his PhD in cellular and molecular biology in 1997 at the Paris XI University, France. He is currently senior lecturer at the School of Medicine at Dundee University. He was co-director of the Inserm- European Associated Laboratory (Toulouse University, France) in...
Rolf A. Brekken
Professor Rolf A. Brekken received his BA in biology from Luther College in Decorah, IA and his PhD from UT Southwestern Medical Center. His graduate studies were focused on developing novel therapies that target the vascular compartment of tumors.
Professor Hani Gabra took his medical degree at Glasgow University in 1987 and his PhD at Edinburgh University in 1996.
Jean Paul Thiery
Professor Jean Paul Thiery is a well-known researcher within the field of cancer therapeutics. Until July 2015 he was professor and head of the Department of Biochemistry of the Yong Loo Lin School of Medicine at the National University of Singapore (NUS). He also held a research director position...
Dr. Watnick received his PhD in biochemistry and biophysics from Columbia University in 1999, and was a postdoctoral fellow with Dr. Robert Weinberg, Whitehead Institute, Cambridge, MA, until 2003.
Mark LaBarge studied genetics at the University of California, Davis, and then earned his PhD in molecular pharmacology at Stanford University in 2004.M He is currently professor at the Department of Population Sciences, and deputy director of the Center for Cancer and Aging at the City of Hope...
Senior Researcher Ritva Heljasvaara received her PhD in 1996 in molecular biology at the University of Oulu, Finland. In 1998 she joined one of the world’s leading extracellular matrix (ECM) and collagen research groups led by Professor Taina Pihlajaniemi at the University of Oulu, and is currently...
Professor Pantel did his MD at the University of Cologne in 1986, Dr. Med. at the University of Cologne in 1987 and Dr. Med. Habil. at the Ludwig-Maximillians-Universitaet in 1995. He is currently director of the Institute of Tumor Biology at the University Medical Center Hamburg-Eppendorf.
Therese Sørlie got her PhD at the University of Oslo in 2000. She is currently currently head of the Department of Cancer Genetics, Institute for Cancer Research at Oslo University Hospital and adjunct professor at the University of Oslo, Medical Faculty.
Professor Arne Östman received his PhD in 1990 on Plateletderived growth factor from the Ludwig Institute for Cancer Research, Uppsala University, Sweden. He is currently professor at the Karolinska Institute (KI).
Ian Mills studied Biochemistry at the University of Oxford, and went on to earn his PhD in Molecular and Cellular Physiology at the University of Liverpool in 2000. He is currently Professor of Translational Prostate Cancer Biology at Queen’s University of Belfast and John Black Associate Professor...
Marta Bertolaso is Professor of Philosophy of Science at the Faculty of Science and Technology for Humans and the Environment and at the Institute of Philosophy of Scientific and Technological Practice, at University Campus Bio-Medico of Rome (UCBM), Italy. She is the director of the Research Unit...
Professor Pollard pioneered studies on the role of macrophages in development and tumor progression. His lab was the first to demonstrate that tumor associated macrophages (TAMs) promote tumor progression and malignancy. His work has focused upon mechanisms behind these pro-tumoral actions of TAMs...
Carina Strell received in December 2021 a Trond Mohn Foundation starting grant for her project Understanding Early Breast Cancer Evolution in Space and Time (EvoMaps). Strell has a long-term collaboration with the Akslen group, and her project will be embedded at CCBIO, commencing in Bergen in 2022.